Key Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8K Buy
312
+294
+1,633% +$13.6K ﹤0.01% 360
2026
Q2
$863 Sell
18
-24
-57% -$1.03K ﹤0.01% 668
2026
Q1
$1.54K Buy
42
+24
+133% +$1.14K ﹤0.01% 570
2025
Q4
$916 Buy
+18
New +$920 ﹤0.01% 443

Other funds holding NVO

Key Capital Management's NVO Position: Q3 2026 in Review

Key Capital Management increased its Novo Nordisk (NVO) stake by 1,633% in Q3 2026, buying an estimated $13.6K and bringing the position to 312 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #360.

Key Capital Management first reported a position in NVO in Q4 2025 and has held it in 4 quarters since. 1,236 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Key Capital Management held 312 shares of Novo Nordisk worth $11.8K as of Q3 2026.
  • Key Capital Management bought 294 Novo Nordisk shares in Q3 2026, an estimated $13.6K.
  • Novo Nordisk made up ﹤0.01% of Key Capital Management's portfolio in Q3 2026, its #360 holding.
  • Key Capital Management first reported a position in Novo Nordisk in Q4 2025 and has held it in 4 quarters since.
  • 1,236 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.